Jupiter Neurosciences Inc.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Jupiter Neurosciences Inc. is a clinical-stage pharmaceutical company focused on developing therapies for neuroinflammation, central nervous system disorders, and selected rare diseases. Its work centers on JOTROL, an enhanced oral resveratrol formulation designed for pharmaceutical use across conditions such as Parkinson’s disease, Alzheimer’s disease, and other neurological disorders. The company also operates a premium nutritional supplements segment through the Nugevia brand, which includes consumer products positioned around longevity, cognitive support, and wellness. Jupiter Neurosciences Inc. combines drug development with consumer health offerings, giving it a presence in both the biopharmaceutical and nutritional supplement markets. Headquartered in Jupiter, Florida, the company is organized around research, formulation technology, and commercial product development in the health sciences sector.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Christer Rosen
- Employees
- 5
- Headquarters
- Jupiter, FL, United States
- Website
- jupiterneurosciences.com